Based on the provided information, there is no mention of any specific committees established by PuraPharm Corp. Ltd. The available context primarily discusses a discloseable and connected transaction involving a patent licence agreement, the issuance of consideration shares under a specific mandate, and related shareholding details. If you require information on committees, further details or additional sources may be needed.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PuraPharm Corp. Ltd. published the original content used to generate this news brief on October 02, 2025, and is solely responsible for the information contained therein.